Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.

Liu SS, Pickens S, Burma NE, Ibarra-Lecue I, Yang H, Xue L, Cook C, Hakimian JK, Severino AL, Lueptow L, Komarek K, Taylor AMW, Olmstead MC, Carroll FI, Bass CE, Andrews AM, Walwyn W, Trang T, Evans CJ, Leslie F, Cahill CM.

J Neurosci. 2019 Mar 12. pii: 0274-19. doi: 10.1523/JNEUROSCI.0274-19.2019. [Epub ahead of print]

PMID:
30862664
2.

Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.

Severino AL, Shadfar A, Hakimian JK, Crane O, Singh G, Heinzerling K, Walwyn WM.

Front Psychiatry. 2018 Apr 23;9:119. doi: 10.3389/fpsyt.2018.00119. eCollection 2018. Review.

3.

Mu-opioid receptors in nociceptive afferents produce a sustained suppression of hyperalgesia in chronic pain.

Severino A, Chen W, Hakimian JK, Kieffer BL, Gaveriaux-Ruff C, Walwyn W, Marvizón JCG.

Pain. 2018 Aug;159(8):1607-1620. doi: 10.1097/j.pain.0000000000001247.

PMID:
29677019
4.

Beta-arrestin 1 regulation of reward-motivated behaviors and glutamatergic function.

Mittal N, Minasyan A, Romaneschi N, Hakimian JK, Gonzalez-Fernandez G, Albert R, Desai N, Mendez IA, Schallert T, Ostlund SB, Walwyn W.

PLoS One. 2017 Oct 3;12(10):e0185796. doi: 10.1371/journal.pone.0185796. eCollection 2017.

Supplemental Content

Loading ...
Support Center